3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
5
Recruiting
4
Terminated
2
Active not recruiting
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
2
Gynecologic
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Anus Neoplasms
1
Interventions
Trastuzumab
77
Capecitabine
59
Cyclophosphamide
54
Paclitaxel
51
Docetaxel
49
Letrozole
44
Fulvestrant
43
Lapatinib
34
Doxorubicin
31
Carboplatin
31
Vinorelbine
30
Bevacizumab
29
Anastrozole
28
pembrolizumab
25
exemestane
24
Tamoxifen
23
Gemcitabine
22
Radiotherapy
21
Albumin-Bound Paclitaxel
19
Everolimus
17
Taxes
16
Epirubicin
15
Ado-Trastuzumab Emtansine
13
130-nm albumin-bound paclitaxel
13
pertuzumab
12
palbociclib
12
liposomal doxorubicin
11
Magnetic Resonance Spectroscopy
11
Filgrastim
11
Cisplatin
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Breast Neoplasms
×
Genetic Testing
×
Clear all
NCT02664389
2026-05-06
PANEL
University Hospital, Rouen
Phase NA
Terminated
289 enrolled
NCT02541188
2021-12-10
MediSein
University Hospital, Montpellier
Terminated
460 enrolled